Performance Evaluation Study for Clearblue Pregnancy Test
Launched by SPD DEVELOPMENT COMPANY LIMITED · Feb 26, 2010
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
Approximately 800 female volunteers wishing to become pregnant will be recruited locally around 5 trial centers within the US.
Daily urine samples and gestational age dating scan information obtained from the study will be used in laboratory tests to assess the accuracy of the Clearblue Pregnancy Test. Product assessment will involve testing of early morning urine samples collected by women during the cycle in which they conceived. Urine samples will be collected pre-conception to the end of the second trimester.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Provide written informed consent to participate in the study and agree to comply with study procedures.
- • Has menstrual bleeds.
- • Seeking to become pregnant.
- • Intend to seek medical care during pregnancy.
- Exclusion Criteria:
- • Has positive pregnancy test on screening.
- • Has received medical treatment for infertility or is participating in an assisted fertility program.
- • Known condition to contra-indicate pregnancy.
About Spd Development Company Limited
SPD Development Company Limited is a leading biopharmaceutical organization dedicated to advancing innovative therapies through rigorous clinical research. With a focus on developing novel treatments across various therapeutic areas, SPD Development emphasizes scientific excellence, patient safety, and regulatory compliance. By leveraging a collaborative approach, the company aims to expedite the delivery of transformative healthcare solutions while adhering to the highest standards of quality and ethics in clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Chicago, Illinois, United States
Edina, Minnesota, United States
Dallas, Texas, United States
San Antonio, Texas, United States
Patients applied
Trial Officials
Phyllis Marx, MD
Principal Investigator
Radiant Research
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials